Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-006595-11Phase 3Completed
Phase 3, randomised trial of progesterone in female infertility and infertility (2 arms), sponsored by IBSA Group. Primary endpoint: Ongoing pregnancy rate at 10 weeks of luteal support. Started Jun 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-006595-11.